Lipodystrophy is a problem with the way your body makes, uses, and stores fat. It's also called fat redistribution. While it used to be more common with older antiretroviral (ART) treatments for ...

Congenital generalised lipodystrophy (CGL) also known as Berardinelli-Seip syndrome is an autosomal recessive disorder characterised by a nearly complete lack of adipose tissue, hypertriglyceridaemia, ...

Entos Pharmaceuticals Inc. has been awarded a $4 million grant by California Institute for Regenerative Medicine (CIRM) to support the completion of IND-enabling activities with ENTLEP-001, a durable ...

Congenital generalized lipodystrophy (CGL), which affects only a few thousand people worldwide, results in severe metabolic disease, diabetes, insulin resistance and reduced life expectancy. With ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Researchers from the Rutgers Robert Wood Johnson Medical School and the Children's Hospital of Orange County discovered a ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...

and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to ...

TEXARKANA, Texas - A Texarkana, Texas boy battling a rare genetic disease is preparing to head to Arkansas Children's ...

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...